{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:15:51Z","timestamp":1782753351663,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/13\/3\/30038"],"award-info":[{"award-number":["FS\/13\/3\/30038"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/18\/19\/33371"],"award-info":[{"award-number":["FS\/18\/19\/33371"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/13\/6\/30180"],"award-info":[{"award-number":["RE\/13\/6\/30180"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/18\/1\/34212"],"award-info":[{"award-number":["RE\/18\/1\/34212"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/16\/8\/32388"],"award-info":[{"award-number":["RG\/16\/8\/32388"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["SP\/F\/22\/150038"],"award-info":[{"award-number":["SP\/F\/22\/150038"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.atherosclerosis.2023.117308","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T17:02:10Z","timestamp":1695920530000},"page":"117308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Human vascular smooth muscle cells utilise chymase for the atypical cleavage and activation of Interleukin-1\u03b2"],"prefix":"10.1016","volume":"390","author":[{"given":"Alejandra","family":"Morales-Maldonado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Humphry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichola","family":"Figg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8215-8885","authenticated-orcid":false,"given":"Murray CH.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2023.117308_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature11603","article-title":"Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability","volume":"492","author":"Zhu","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib4","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1073\/pnas.092324399","article-title":"Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size","volume":"99","author":"Devlin","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib6","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1161\/01.CIR.0000142085.39015.31","article-title":"Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and\/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications","volume":"110","author":"Chi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib7","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/01.ATV.0000127025.48140.a3","article-title":"Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice","volume":"24","author":"Isoda","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.cardiores.2005.01.008","article-title":"Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice","volume":"66","author":"Merhi-Soussi","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2006.11.026","article-title":"Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism","volume":"195","author":"Kamari","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib10","doi-asserted-by":"crossref","first-page":"e5073","DOI":"10.1371\/journal.pone.0005073","article-title":"Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding","volume":"4","author":"Chamberlain","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib11","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib12","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbrc.2011.01.008","article-title":"Reduced atherosclerosis and inflammatory cytokines in apolipoprotein-E-deficient mice lacking bone marrow-derived interleukin-1alpha","volume":"405","author":"Kamari","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2011.02.026","article-title":"Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice","volume":"216","author":"Bhaskar","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2704","article-title":"Fatty acid-induced mitochondrial uncoupling elicits inflammasome-independent IL-1alpha and sterile vascular inflammation in atherosclerosis","volume":"14","author":"Freigang","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1172\/JCI43713","article-title":"Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice","volume":"122","author":"Alexander","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvad091","article-title":"Thrombin activated interleukin-1\u03b1 drives atherogenesis, but also promotes VSMC proliferation and collagen production","author":"Burzynski","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajamaki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib20","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1038\/cddis.2011.18","article-title":"Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome","volume":"2","author":"Menu","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.613170","article-title":"Alternative pathways of IL-1 activation, and its role in health and disease","volume":"11","author":"Pyrillou","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib22","doi-asserted-by":"crossref","first-page":"24067","DOI":"10.1074\/jbc.M115.659029","article-title":"Neutrophil elastase promotes interleukin-1beta secretion from human coronary endothelium","volume":"290","author":"Alfaidi","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib23","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.immuni.2019.03.003","article-title":"The coagulation and immune systems are directly linked through the activation of interleukin-1alpha by thrombin","volume":"50","author":"Burzynski","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nm.3866","article-title":"KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis","volume":"21","author":"Shankman","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.immuni.2013.01.008","article-title":"Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1alpha, controlling necrosis-induced sterile inflammation","volume":"38","author":"Zheng","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2016.01.012","article-title":"Human monocytes engage an alternative inflammasome pathway","volume":"44","author":"Gaidt","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib27","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1084\/jem.191.9.1535","article-title":"The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells","volume":"191","author":"Young","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib28","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.4049\/jimmunol.1500509","article-title":"Multiple cathepsins promote pro-IL-1beta synthesis and NLRP3-mediated IL-1beta activation","volume":"195","author":"Orlowski","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib29","doi-asserted-by":"crossref","first-page":"25897","DOI":"10.1016\/S0021-9258(18)47330-9","article-title":"Processing of procarboxypeptidase A and other zymogens in murine mast cells","volume":"269","author":"Dikov","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228546","article-title":"Extended cleavage specificity of the rat vascular chymase, a potential blood pressure regulating enzyme expressed by rat vascular smooth muscle cells","volume":"21","author":"Berglund","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1172\/JCI9997","article-title":"A novel vascular smooth muscle chymase is upregulated in hypertensive rats","volume":"107","author":"Guo","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib32","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1161\/ATVBAHA.115.305896","article-title":"Senescent vascular smooth muscle cells drive inflammation through an interleukin-1alpha-dependent senescence-associated secretory phenotype","volume":"35","author":"Gardner","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib33","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1084\/jem.185.7.1287","article-title":"Human vascular smooth muscle cells express interleukin-1 beta- converting enzyme (ICE), but inhibit processing of the interleukin-1 beta precursor by ICE","volume":"185","author":"Schonbeck","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib34","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yjmcc.2017.12.007","article-title":"Calcium phosphate particles stimulate interleukin-1beta release from human vascular smooth muscle cells: a role for spleen tyrosine kinase and exosome release","volume":"115","author":"Dautova","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.565924","article-title":"Priming is dispensable for NLRP3 inflammasome activation in human monocytes in vitro","volume":"11","author":"Gritsenko","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib36","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1084\/jem.174.4.821","article-title":"Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase","volume":"174","author":"Mizutani","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCRESAHA.109.208389","article-title":"Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis","volume":"106","author":"Clarke","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41586-019-1167-6","article-title":"Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death","volume":"569","author":"Silvestre-Roig","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2023.117308_bib39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/01.RES.0000090993.01633.D4","article-title":"Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-\/-mice","volume":"93","author":"Bot","year":"2003","journal-title":"Circ. Res."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023052292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915023052292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:55:05Z","timestamp":1758156905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915023052292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":39,"alternative-id":["S0021915023052292"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117308","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human vascular smooth muscle cells utilise chymase for the atypical cleavage and activation of Interleukin-1\u03b2","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2023.117308","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117308"}}